Author

Cassandra C. Garbutt

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:multiome· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin Haibe‐KainsiD· 2 shared Christopher B. LietziD· 2 shared Dimitrios SpentzosiD· 2 shared Edwin ChoyiD· 2 shared Gregory Michael CoteiD· 2 shared Aedín C. CulhaneiD· 1 shared Ahmed RattaniiD· 1 shared Andrew D. KellyiD· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Benjamin Haibe‐KainsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.

Christopher B. Lietz, Cassandra C. Garbutt, William Thomas Barry, Vikram Deshpande, Yen‐Lin Chen, Santiago A. Lozano‐Calderón, Yaoyu E. Wang, Brian P. Lawney, David H. Ebb, Gregory Michael Cote, Zhenfeng Duan, Francis John Hornicek, Edwin Choy, G. Petur Nielsen, Benjamin Haibe‐Kains, , Dimitrios Spentzos

The paper identifies microRNA-mRNA networks associated with prognosis in osteosarcoma and validates their predictive value across independent datasets.

Scientific Reports · Mar 10, 2020Peer-reviewedGenetic & Genomic Medicine

Machine learning-based prediction of response to PARP inhibition across cancer types.

Katherine E. Hill, Ahmed Rattani, Christopher E. Lietz, Cassandra C. Garbutt, Edwin Choy, Gregory Michael Cote, Aedín C. Culhane, Andrew D. Kelly, Benjamin Haibe‐Kains, Dimitrios Spentzos

The paper develops a multi-gene signature predicting PARP inhibitor response across cancer types using machine learning and validates it in vitro and in clinical datasets.

medRxiv · Sep 27, 2019 · PreprintGenetic & Genomic Medicine